Last reviewed · How we verify
NCT04444531
Ozone Therapy and Coronavirus Disease of 2019 (COVID-19) Pneumonia
trial in COVID-19 Pneumonia in 18 participants. Completed in 26 May 2020.
19 May 2020
Quick facts
| Lead sponsor | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 18 |
| Start date | 20 March 2020 |
| Primary completion | 19 May 2020 |
| Estimated completion | 26 May 2020 |
| Sites | 1 location across Spain |
Conditions studied
- COVID-19 Pneumonia — all drugs for COVID-19 Pneumonia →
Sponsor
Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
Who can join
Eligibility, any sex, with COVID-19 Pneumonia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective is to determine whether the use of ozone autohemotherapy is associated with a decrease in time to clinical improvement
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Ozone therapy for patients with COVID-19 pneumonia: Preliminary report of a prospective case-control study.
Hernández A, Viñals M, Pablos A, Vilás F, et al · · 2021 · cited 27× · PMID 33310665 · DOI 10.1016/j.intimp.2020.107261
Verify or expand the search:
- PubMed search for NCT04444531
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID-19 Pneumonia
Currently open trials in the same condition.
- NCT06601998 — Cardiovascular Disease Progression in Survivors of Community Acquired Pneumonia and Lung Infection by Covid-19. · recruiting
- NCT06501599 — AI-based System for Assessing Suspected Viral Pneumonia Related Lung Changes · recruiting
- NCT06402318 — Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine · recruiting
- NCT05765396 — SARS-CoV-2/COVID-19 Study of Next Generation Non-Invasive Passive Detection Technologies · active not recruiting
- NCT06927622 — Corona Virus Disease 2019 Cohort Study · recruiting
Other Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta trials
Trials by the same sponsor.
- NCT06869941 — Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis · recruiting
- NCT07502053 — Evaluation of the Perfusion of the Pancreatic Remnant With Indocyanine Green and Its Impact on the Reduction of Pancreat · NA · recruiting
- NCT06442215 — Selection of Surgical Technique in Rectal Cancer · recruiting
- NCT06220045 — Comparing PP and PVDF Meshes in Midline Laparotomy Closure for High-risk Colorectal Surgery. Impact on Incisional Hernia · NA · recruiting
- NCT06135857 — Electromuscular Stimulation Therapy as a Prophylactic Method to Reduce Thromboses Related to PICC Catheters in Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04444531 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- Last refreshed: 25 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04444531.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing